TLR2 upregulates membrane type 1 matrix metalloprotease (MT1-MMP) and metallopeptidase 14 (MMP14) in MG to activate glioma-sourced MMP2 when responding to TLR2 endogenous ligands and thereby facilitate glioma invasion (43). The gene discussed is TLR2; the disease is central nervous system cancer.